HORIZON PHARMA PLC's ticker is and the CUSIP is G4617B955. A total of 1 filers reported holding HORIZON PHARMA PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $885,000 | -22.4% | 33,500 | -42.6% | 0.01% | 0.0% |
| Q4 2018 | $1,141,000 | +0.1% | 58,400 | +0.3% | 0.01% | +11.1% |
| Q3 2018 | $1,140,000 | +10.7% | 58,200 | -6.4% | 0.01% | 0.0% |
| Q2 2018 | $1,030,000 | -26.4% | 62,200 | -36.9% | 0.01% | -35.7% |
| Q1 2018 | $1,399,000 | +9.7% | 98,500 | +12.8% | 0.01% | +55.6% |
| Q4 2017 | $1,275,000 | +72.5% | 87,300 | +49.7% | 0.01% | +28.6% |
| Q3 2017 | $739,000 | -19.5% | 58,300 | -24.6% | 0.01% | -30.0% |
| Q2 2017 | $918,000 | -69.6% | 77,300 | -62.1% | 0.01% | -71.4% |
| Q1 2017 | $3,015,000 | -81.4% | 204,000 | -79.7% | 0.04% | -77.7% |
| Q4 2016 | $16,227,000 | +169.4% | 1,002,900 | +201.9% | 0.16% | +141.5% |
| Q3 2016 | $6,023,000 | +137.6% | 332,200 | +115.9% | 0.06% | +116.7% |
| Q2 2016 | $2,535,000 | -41.1% | 153,900 | -40.7% | 0.03% | -50.8% |
| Q1 2016 | $4,302,000 | -28.5% | 259,600 | -6.5% | 0.06% | -14.1% |
| Q4 2015 | $6,016,000 | +93.7% | 277,600 | +77.2% | 0.07% | +65.1% |
| Q3 2015 | $3,106,000 | +76.7% | 156,700 | +209.7% | 0.04% | +72.0% |
| Q2 2015 | $1,758,000 | -22.2% | 50,600 | -41.8% | 0.02% | -28.6% |
| Q1 2015 | $2,259,000 | +129.1% | 87,000 | +13.7% | 0.04% | +133.3% |
| Q4 2014 | $986,000 | +10.3% | 76,500 | +5.1% | 0.02% | +7.1% |
| Q3 2014 | $894,000 | – | 72,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 259,600 | $4,302,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 390 | $646,000 | 0.03% |
| SIMPLEX TRADING, LLC | 276 | $53,000 | 0.00% |
| Citadel Advisors | 96,700 | $1,602,000 | 0.00% |